ArticleFrontiers in medicine2025
Leveraging advanced feature extraction for improved kidney biopsy segmentation.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A lightweight ResNet50V2-ECA model for renal cell carcinoma grading: efficiency, calibration, and state-of-the-art performance.Scientific reports · 2026Article
- Glomeruli detection and classification in histopathological images using deep learning semantic segmentation.BMC medical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical image segmentation faces critical challenges in renal histopathology due to the intricate morphology of glomeruli characterized by small size, fragmented structures, and low contrast against complex tissue backgrounds. While the Segment Anything Model (SAM) excels in natural image segmentation, its direct application to medical imaging underperforms due to (1) insufficient preservation of fine-grained anatomical details, (2) computational inefficiency on gigapixel whole-slide images (WSIs), and (3) poor adaptation to domain-specific features like staining variability and sparse annotations. To address these limitations, we propose V-SAM, a novel framework enhancing SAM's architecture through three key innovations: (1) a V-shaped adapter that preserves spatial hierarchies via multi-scale skip connections, recovering capillary-level details lost in SAM's aggressive downsampling; (2) lightweight adapter layers that fine-tune SAM's frozen encoder with fewer trainable parameters, optimizing it for histopathology textures while avoiding catastrophic forgetting; and (3) a dynamic point-prompt mechanism enabling sub-pixel refinement of glomerular boundaries through gradient aware localization. Evaluated on the HuBMAP Hacking the Human Vasculature and Hacking the Kidney datasets, V-SAM achieves state-of-the-art performance, surpassing 89.31%, 97.65% accuracy, 86.17%, 95.54% F1-score respectively. V-SAM sets a new paradigm for adapting foundation models to clinical workflows, with direct applications in chronic kidney disease diagnosis and biomarker discovery. This work bridges the gap between SAM's generalizability and the precision demands of medical imaging, offering a scalable solution for resource constrained healthcare environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.